Research @ UVA Engineering

Brent A. French combines advanced methods of targeted drug and gene delivery with biomedical imaging in vivo to explore novel targets and treatment strategies in cardiovascular disease. Research interests of the Molecular Bioengineering Lab focus on developing new, more effective strategies for treating and preventing human disease.

Our group focuses on the synthesis of well-defined nanoparticles, their dispersion into polymer solutions and melts, and their suspension rheology. With our fundamental studies, we seek to optimize processing to achieve a desirable microstructure in industrial suspensions, and to set a foundation for developing constitutive rheological models.

Donald Griffin improves clinical translation of acellular and cellular therapies through enhanced hydrogel-tissue integration, specifically focusing on the development of passive and active instructional microenvironments using microscale building blocks.

Christopher Highley develops materials and fabrication technologies to enable the design and construction of complex cellular and material systems, with the goal of addressing fundamental and translational problems in biomedicine. 

Patrick E. Hopkins is a Whitney Stone Professor in Engineering at the University of Virginia, with a primary appointment in the Department of Mechanical and Aerospace Engineering, and courtesy appointments in the Department of Materials Science and Engineering and the Department of Physics. He is also the director of the ExSiTE Lab.

Kelsey Kubelick leverages light, sound, nanoconstruct design and cellular engineering strategies to develop advanced theranostic imaging platforms. With a special interest in ultrasound and photoacoustics, her lab creates imaging tools that play a critical role in informing, guiding and enhancing therapies across a range of biomedical applications.

Kyle Lampe is an Associate Professor in the Department of Chemical Engineering at the University of Virginia, and by courtesy, Biomedical Engineering and Neuroscience.

Shayn Peirce-Cottler develops computational models and combines them with wet lab experiments and machine learning to study how tissues heal after injury and to develop new therapies for inducing tissue regeneration.

Jeff Saucerman, PhD, Professor of Biomedical Engineering, combines computational models and high-throughput experiments to discover molecular networks and drugs that control cardiac remodeling.

Evan Scott, renowned for his groundbreaking work in nanotechnology to address cancer, glaucoma, heart disease, and other conditions, leads the Institute for Nanoscale Scientific and Technological Advanced Research (nanoSTAR) and brings considerable experience to the BME in areas of biomaterials science, nanotechnology, and tissue engineering.